You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Prostate cancer

trublood-prostate for triaging and diagnosing people with prostate cancer symptoms

  • Medtech innovation briefing
  • Reference number: MIB268
  • Published:  13 July 2021

Download (PDF)
  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing

Regulatory information

trublood-prostate is a CE-marked class general in vitro diagnostic regulated under the directive 98/79/EC. Renewal is due in July 2021.


Next page Equality considerations Previous page The technology
Back to top